Dark

Check out our Dark Pool Levels

NTRP
NextTrip, Inc. Common Stock
stock NASDAQ

At Close

Feb 12, 2026 3:59:30 PM EST

3.07USD0.000%(0.00)28,622

0.00Bid 0.00Ask 0.00Spread

Pre-market

Feb 13, 2026 9:11:30 AM EST

2.91USD-5.212%(-0.16)290

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Feb 4, 2021

09:03AM EST Synthetic Bryostatin Available to Expand Neurodegenerative Indication Trials PR Newswire

Dec 2, 2020

09:13AM EST Neurotrope And Metuchen Pharma Complete Merger Forming Petros Pharmaceuticals RTTNews

09:04AM EST Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming PR Newswire

Nov 20, 2020

01:38PM EST Neurotrope shares were trading higher after the company announced that its board approved a spin-off of Neurotrope Bioscience. Benzinga

09:03AM EST Neurotrope Board Approves Spin-Off Of Neurotrope Bioscience And Sets Record And Distribution Dates RTTNews

09:01AM EST Neurotrope, Inc. Board Approves Spin-Off Of Neurotrope Bioscience, Inc. Benzinga

09:01AM EST Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets PR Newswire

Nov 2, 2020

10:00AM EST Insider Buys Neurotrope Stock Benzinga

Oct 26, 2020

11:36AM EDT Insider Buys Neurotrope's Stock Benzinga

Oct 22, 2020

12:04PM EDT Insider Buys Neurotrope Stock Benzinga

Oct 20, 2020

11:21AM EDT Insider Buys Neurotrope's Stock Benzinga

Oct 19, 2020

11:44AM EDT Insider Buys Neurotrope's Shares Benzinga

Oct 6, 2020

09:05AM EDT Neurotrope Announces First Patient Dosed In Long-Term Clinical Trial Of Bryostatin In Alzheimer's Disease Benzinga

09:04AM EDT Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of PR Newswire

Sep 30, 2020

09:23AM EDT Neurotrope In 8K Filing Announces 24.75M Shares Of Petros To Be Issued To Co As Part Of Previously Disclosed Merger Benzinga

09:15AM EDT Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger PR Newswire

Jul 30, 2020

09:08AM EDT Neurotrope Bioscience To Conduct Ongoing Phase 2 Study Of Bryostatin-1, Partially Funded By NIH, For Alzheimer's Disease RTTNews

09:02AM EDT Neurotrope Reports Deal With Worldwide Clinical Trials To Conduct Ongoing Phase 2 Study Of Bryostatin-1 For Alzheimer's Benzinga

09:01AM EDT Conduct Ongoing Phase 2 Study of Bryostatin-1, Partially Funded by NIH, for Alzheimer's Disease PR Newswire

Share